-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
المؤلفون: Poort VM; Princess Maxima Center, Utrecht, Netherlands., Hagelaar R; Princess Máxima Center, Utrecht, Netherlands., van Roosmalen MJ; Princess Máxima Center for pediatric oncology, Utrecht, Netherlands., Trabut L; Princess Máxima Center, Utrecht, Netherlands., Buijs-Gladdines JGCAM; Princess Maxima Center for Pediatric Oncology, Utrecht, Utrecht, Netherlands., van Wijk B; University Medical Center Utrecht, Netherlands., Meijerink J; Prinses Maxima Center., van Boxtel R; Princess Máxima Center, Utrecht, Netherlands.
المصدر: Cancer research [Cancer Res] 2024 Jun 17. Date of Electronic Publication: 2024 Jun 17.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
-
3دورية أكاديمية
المؤلفون: Van Hulst AM; Princess Maxima Center for Pediatric Oncology, Utrecht. a.vanhulst@prinsesmaximacentrum.nl., Van der Zwet JCG; Princess Maxima Center for Pediatric Oncology, Utrecht., Buijs-Gladdines JGCAM; Princess Maxima Center for Pediatric Oncology, Utrecht., Smits WK; Princess Maxima Center for Pediatric Oncology, Utrecht., Fiocco M; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands; Mathematical Institute, Leiden University, Leiden, The Netherlands; Department of Biomedical data Science, Medical Statistics, Leiden University Medical Centre., Pieters R; Princess Maxima Center for Pediatric Oncology, Utrecht., Van Leeuwen FN; Princess Maxima Center for Pediatric Oncology, Utrecht., Van den Heuvel-Eibrink MM; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands; Child Health, UMCU-Wilhelmina Children's Hospital, Utrecht. m.m.vandenheuvel-eibrink@prinsesmaximacentrum.nl., Van den Akker ELT; Pediatric Endocrinology, Erasmus MC- Sophia Children's Hospital, Rotterdam., Meijerink JPP; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands; Presently working at Acerta-Pharma (AstraZeneca), Oss.
المصدر: Haematologica [Haematologica] 2024 May 01; Vol. 109 (5), pp. 1551-1556. Date of Electronic Publication: 2024 May 01.
نوع المنشور: Letter; Research Support, Non-U.S. Gov't; Journal Article
بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
-
4دورية أكاديمية
المؤلفون: Smits WK; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Vermeulen C; Oncode Institute, Utrecht, the Netherlands; Hubrecht Institute-KNAW, Utrecht, the Netherlands; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands., Hagelaar R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Kimura S; Laboratory of Pathology, St. Jude's Children's Research Hospital, Memphis TN, USA., Vroegindeweij EM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Buijs-Gladdines JGCAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van de Geer E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Verstegen MJAM; Oncode Institute, Utrecht, the Netherlands; Hubrecht Institute-KNAW, Utrecht, the Netherlands., Splinter E; Cergentis BV, Utrecht, the Netherlands., van Reijmersdal SV; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Buijs A; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Galjart N; Department of Cell Biology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., van Eyndhoven W; Diagnostics and Genomics Group, Agilent Technologies, Amstelveen, the Netherlands., van Min M; Cergentis BV, Utrecht, the Netherlands., Kuiper R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Kemmeren P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Mullighan CG; Laboratory of Pathology, St. Jude's Children's Research Hospital, Memphis TN, USA., de Laat W; Oncode Institute, Utrecht, the Netherlands; Hubrecht Institute-KNAW, Utrecht, the Netherlands., Meijerink JPP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: jules.meijerink@acerta-pharma.com.
المصدر: Cell reports [Cell Rep] 2023 Apr 25; Vol. 42 (4), pp. 112373. Date of Electronic Publication: 2023 Apr 14.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics, Humans ; CCCTC-Binding Factor/genetics ; CCCTC-Binding Factor/metabolism ; Chromatin ; Enhancer Elements, Genetic/genetics ; Mutation ; Oncogenes ; Repressor Proteins/genetics ; Repressor Proteins/metabolism ; Transcription Factors/metabolism ; Tumor Suppressor Proteins/metabolism
-
5دورية أكاديمية
المؤلفون: Van der Zwet JCG; Princess Maxima Center for Pediatric Oncology, Utrecht., Cordo' V; Princess Maxima Center for Pediatric Oncology, Utrecht., Buijs-Gladdines JGCAM; Princess Maxima Center for Pediatric Oncology, Utrecht., Hagelaar R; Princess Maxima Center for Pediatric Oncology, Utrecht., Smits WK; Princess Maxima Center for Pediatric Oncology, Utrecht., Vroegindeweij E; Princess Maxima Center for Pediatric Oncology, Utrecht., Graus LTM; Princess Maxima Center for Pediatric Oncology, Utrecht., Poort V; Princess Maxima Center for Pediatric Oncology, Utrecht., Nulle M; Princess Maxima Center for Pediatric Oncology, Utrecht., Pieters R; Princess Maxima Center for Pediatric Oncology, Utrecht., Meijerink JPP; Princess Maxima Center for Pediatric Oncology, Utrecht. j.meijerink@prinsesmaximacentrum.nl.
المصدر: Haematologica [Haematologica] 2023 Mar 01; Vol. 108 (3), pp. 732-746. Date of Electronic Publication: 2023 Mar 01.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
مواضيع طبية MeSH: Glucocorticoids*/pharmacology , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism, Humans ; Child ; STAT5 Transcription Factor/metabolism ; Steroids ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; T-Lymphocytes/metabolism ; Apoptosis
-
6دورية أكاديميةMAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance.
المؤلفون: van der Zwet JCG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Buijs-Gladdines JGCAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Cordo' V; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Debets DO; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center of Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Smits WK; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Chen Z; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Dylus J; Netherlands Translational Research Center B.V., Oss, the Netherlands., Zaman GJR; Netherlands Translational Research Center B.V., Oss, the Netherlands., Altelaar M; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center of Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Oshima K; Institute of Cancer Genetics, Columbia University Medical Center, New York, NY, USA., Bornhauser B; Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Bourquin JP; Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Cools J; KU Leuven Center for Human Genetics & VIB Center for Cancer Biology, Leuven, Belgium., Ferrando AA; Institute of Cancer Genetics, Columbia University Medical Center, New York, NY, USA., Vormoor J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Newcastle University, Newcastle upon Tyne, UK., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Vormoor B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Meijerink JPP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. j.meijerink@prinsesmaximacentrum.nl.
المصدر: Leukemia [Leukemia] 2021 Dec; Vol. 35 (12), pp. 3394-3405. Date of Electronic Publication: 2021 May 18.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
مواضيع طبية MeSH: Drug Resistance, Neoplasm*, Extracellular Signal-Regulated MAP Kinases/*metabolism , Mitogen-Activated Protein Kinases/*metabolism , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy , Protein Kinase Inhibitors/*pharmacology , Steroids/*pharmacology, Animals ; Apoptosis ; Extracellular Signal-Regulated MAP Kinases/genetics ; Humans ; Interleukin-7 ; Janus Kinase 1/genetics ; Janus Kinase 1/metabolism ; Mice ; Mitogen-Activated Protein Kinases/genetics ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/metabolism ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Receptors, Interleukin-7 ; Signal Transduction ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
-
7دورية أكاديمية
المؤلفون: van der Zwet JCG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Smits W; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Buijs-Gladdines JGCAM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Meijerink JPP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
المصدر: HemaSphere [Hemasphere] 2020 Dec 21; Vol. 5 (1), pp. e513. Date of Electronic Publication: 2020 Dec 21 (Print Publication: 2021).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE